1 Factor IX Complex Drug Market Overview
1.1 Product Overview and Scope of Factor IX Complex Drug
1.2 Factor IX Complex Drug Segment by Type
1.2.1 Global Factor IX Complex Drug Market Value Comparison by Type (2023-2029)
1.2.2 Beriplex
1.2.3 Profilnine
1.2.4 Octaplex
1.2.5 Prothromplex
1.2.6 Cofact
1.2.7 Other
1.3 Factor IX Complex Drug Segment by Application
1.3.1 Global Factor IX Complex Drug Market Value by Application: (2023-2029)
1.3.2 Hemophilia B
1.3.3 Acquired Coagulation Factor Deficiency
1.4 Global Factor IX Complex Drug Market Size Estimates and Forecasts
1.4.1 Global Factor IX Complex Drug Revenue 2018-2029
1.4.2 Global Factor IX Complex Drug Sales 2018-2029
1.4.3 Global Factor IX Complex Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Factor IX Complex Drug Market Competition by Manufacturers
2.1 Global Factor IX Complex Drug Sales Market Share by Manufacturers (2018-2023)
2.2 Global Factor IX Complex Drug Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Factor IX Complex Drug Average Price by Manufacturers (2018-2023)
2.4 Global Factor IX Complex Drug Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Factor IX Complex Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Factor IX Complex Drug, Product Type & Application
2.7 Factor IX Complex Drug Market Competitive Situation and Trends
2.7.1 Factor IX Complex Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Factor IX Complex Drug Players Market Share by Revenue
2.7.3 Global Factor IX Complex Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Factor IX Complex Drug Retrospective Market Scenario by Region
3.1 Global Factor IX Complex Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Factor IX Complex Drug Global Factor IX Complex Drug Sales by Region: 2018-2029
3.2.1 Global Factor IX Complex Drug Sales by Region: 2018-2023
3.2.2 Global Factor IX Complex Drug Sales by Region: 2024-2029
3.3 Global Factor IX Complex Drug Global Factor IX Complex Drug Revenue by Region: 2018-2029
3.3.1 Global Factor IX Complex Drug Revenue by Region: 2018-2023
3.3.2 Global Factor IX Complex Drug Revenue by Region: 2024-2029
3.4 North America Factor IX Complex Drug Market Facts & Figures by Country
3.4.1 North America Factor IX Complex Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Factor IX Complex Drug Sales by Country (2018-2029)
3.4.3 North America Factor IX Complex Drug Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Factor IX Complex Drug Market Facts & Figures by Country
3.5.1 Europe Factor IX Complex Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Factor IX Complex Drug Sales by Country (2018-2029)
3.5.3 Europe Factor IX Complex Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Factor IX Complex Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Factor IX Complex Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Factor IX Complex Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific Factor IX Complex Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Factor IX Complex Drug Market Facts & Figures by Country
3.7.1 Latin America Factor IX Complex Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Factor IX Complex Drug Sales by Country (2018-2029)
3.7.3 Latin America Factor IX Complex Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Factor IX Complex Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Factor IX Complex Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Factor IX Complex Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa Factor IX Complex Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Factor IX Complex Drug Sales by Type (2018-2029)
4.1.1 Global Factor IX Complex Drug Sales by Type (2018-2023)
4.1.2 Global Factor IX Complex Drug Sales by Type (2024-2029)
4.1.3 Global Factor IX Complex Drug Sales Market Share by Type (2018-2029)
4.2 Global Factor IX Complex Drug Revenue by Type (2018-2029)
4.2.1 Global Factor IX Complex Drug Revenue by Type (2018-2023)
4.2.2 Global Factor IX Complex Drug Revenue by Type (2024-2029)
4.2.3 Global Factor IX Complex Drug Revenue Market Share by Type (2018-2029)
4.3 Global Factor IX Complex Drug Price by Type (2018-2029)
5 Segment by Application
5.1 Global Factor IX Complex Drug Sales by Application (2018-2029)
5.1.1 Global Factor IX Complex Drug Sales by Application (2018-2023)
5.1.2 Global Factor IX Complex Drug Sales by Application (2024-2029)
5.1.3 Global Factor IX Complex Drug Sales Market Share by Application (2018-2029)
5.2 Global Factor IX Complex Drug Revenue by Application (2018-2029)
5.2.1 Global Factor IX Complex Drug Revenue by Application (2018-2023)
5.2.2 Global Factor IX Complex Drug Revenue by Application (2024-2029)
5.2.3 Global Factor IX Complex Drug Revenue Market Share by Application (2018-2029)
5.3 Global Factor IX Complex Drug Price by Application (2018-2029)
6 Key Companies Profiled
6.1 CSL Behring
6.1.1 CSL Behring Corporation Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring Factor IX Complex Drug Sales, Revenue and Gross Margin (2018-2023)
6.1.4 CSL Behring Factor IX Complex Drug Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Corporation Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Factor IX Complex Drug Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Grifols Factor IX Complex Drug Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 Octapharma
6.3.1 Octapharma Corporation Information
6.3.2 Octapharma Description and Business Overview
6.3.3 Octapharma Factor IX Complex Drug Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Octapharma Factor IX Complex Drug Product Portfolio
6.3.5 Octapharma Recent Developments/Updates
6.4 Prothya Biosolutions
6.4.1 Prothya Biosolutions Corporation Information
6.4.2 Prothya Biosolutions Description and Business Overview
6.4.3 Prothya Biosolutions Factor IX Complex Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Prothya Biosolutions Factor IX Complex Drug Product Portfolio
6.4.5 Prothya Biosolutions Recent Developments/Updates
6.5 Takeda
6.5.1 Takeda Corporation Information
6.5.2 Takeda Description and Business Overview
6.5.3 Takeda Factor IX Complex Drug Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Takeda Factor IX Complex Drug Product Portfolio
6.5.5 Takeda Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Factor IX Complex Drug Industry Chain Analysis
7.2 Factor IX Complex Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Factor IX Complex Drug Production Mode & Process
7.4 Factor IX Complex Drug Sales and Marketing
7.4.1 Factor IX Complex Drug Sales Channels
7.4.2 Factor IX Complex Drug Distributors
7.5 Factor IX Complex Drug Customers
8 Factor IX Complex Drug Market Dynamics
8.1 Factor IX Complex Drug Industry Trends
8.2 Factor IX Complex Drug Market Drivers
8.3 Factor IX Complex Drug Market Challenges
8.4 Factor IX Complex Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
第IX因子複合薬のグローバル市場2023年：ベリプレックス、プロフィルニン、オクタプレックス、プロトロンプレックス、コファクト、その他 |
| 【英語タイトル】Global Factor IX Complex Drug Market Research Report 2023 | |
 | ・商品コード：QYR23MA8757 ・発行会社（調査会社）：QYResearch ・発行日：2023年3月 ・ページ数：91 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル ・産業分野：医薬品 |
| Single User（1名様閲覧用） | USD2,900 ⇒換算￥377,000 | 見積依頼/購入/質問フォーム |
| Multi User（5名様閲覧用） | USD4,350 ⇒換算￥565,500 | 見積依頼/購入/質問フォーム |
| Enterprise License（同一法人内共有可） | USD5,800 ⇒換算￥754,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 本調査レポートは世界の第IX因子複合薬市場について調査・分析し、世界の第IX因子複合薬市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（ベリプレックス、プロフィルニン、オクタプレックス、プロトロンプレックス、コファクト、その他）、用途別セグメント分析（血友病B、後天性血液凝固因子欠乏症）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、CSL Behring、Grifols、Octapharma、Prothya Biosolutions、Takedaなどが含まれています。世界の第IX因子複合薬市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、第IX因子複合薬市場規模を推定する際に考慮しました。 ・第IX因子複合薬市場の概要 - 製品の定義 - 第IX因子複合薬のタイプ別セグメント - 世界の第IX因子複合薬市場規模：タイプ別分析（ベリプレックス、プロフィルニン、オクタプレックス、プロトロンプレックス、コファクト、その他） - 第IX因子複合薬の用途別セグメント - 世界の第IX因子複合薬市場規模：用途別分析（血友病B、後天性血液凝固因子欠乏症） - 世界の第IX因子複合薬市場規模予測（2018年-2029年） - 第IX因子複合薬の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 第IX因子複合薬市場の競争状況およびトレンド ・第IX因子複合薬の地域別市場規模 - 北米の第IX因子複合薬市場規模（2018年-2029年） - アメリカの第IX因子複合薬市場規模（2018年-2029年） - ヨーロッパの第IX因子複合薬市場規模（2018年-2029年） - アジア太平洋の第IX因子複合薬市場規模（2018年-2029年） - 中国の第IX因子複合薬市場規模（2018年-2029年） - 日本の第IX因子複合薬市場規模（2018年-2029年） - 韓国の第IX因子複合薬市場規模（2018年-2029年） - インドの第IX因子複合薬市場規模（2018年-2029年） - オーストラリアの第IX因子複合薬市場規模（2018年-2029年） - 中南米の第IX因子複合薬市場規模（2018年-2029年） - 中東・アフリカの第IX因子複合薬市場規模（2018年-2029年） ・タイプ別セグメント：ベリプレックス、プロフィルニン、オクタプレックス、プロトロンプレックス、コファクト、その他 - 世界の第IX因子複合薬のタイプ別販売量（2018年-2023年） - 世界の第IX因子複合薬のタイプ別売上（2018年-2023年） - 世界の第IX因子複合薬のタイプ別価格 ・用途別セグメント：血友病B、後天性血液凝固因子欠乏症 - 世界の第IX因子複合薬の用途別販売量（2018年-2023年） - 世界の第IX因子複合薬の用途別売上（2018年-2023年） - 世界の第IX因子複合薬の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 CSL Behring、Grifols、Octapharma、Prothya Biosolutions、Takeda ・産業チェーンと販売チャネルの分析 - 第IX因子複合薬産業チェーン分析 - 第IX因子複合薬の主要原材料 - 第IX因子複合薬の販売チャネル - 第IX因子複合薬のディストリビューター - 第IX因子複合薬の主要顧客 ・第IX因子複合薬市場ダイナミクス - 第IX因子複合薬の業界動向 - 第IX因子複合薬市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Highlights
The global Factor IX Complex Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Factor IX Complex Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Factor IX Complex Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Factor IX Complex Drug include CSL Behring, Grifols, Octapharma, Prothya Biosolutions and Takeda, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Factor IX Complex Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Factor IX Complex Drug.
The Factor IX Complex Drug market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Factor IX Complex Drug market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Factor IX Complex Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
CSL Behring
Grifols
Octapharma
Prothya Biosolutions
Takeda
Segment by Type
Beriplex
Profilnine
Octaplex
Prothromplex
Cofact
Other
Segment by Application
Hemophilia B
Acquired Coagulation Factor Deficiency
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Factor IX Complex Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Factor IX Complex Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
| ★調査レポート[第IX因子複合薬のグローバル市場2023年：ベリプレックス、プロフィルニン、オクタプレックス、プロトロンプレックス、コファクト、その他] (コード：QYR23MA8757)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[第IX因子複合薬のグローバル市場2023年：ベリプレックス、プロフィルニン、オクタプレックス、プロトロンプレックス、コファクト、その他]についてメールでお問い合わせ |
